Home/Filings/4/0001437749-24-026802
4//SEC Filing

Reynolds Mark 4

Accession 0001437749-24-026802

CIK 0000832489other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:10 PM ET

Size

5.2 KB

Accession

0001437749-24-026802

Insider Transaction Report

Form 4
Period: 2024-08-12
Reynolds Mark
Chief Financial Officer
Transactions
  • Award

    Stock Option

    2024-08-12+15,70015,700 total
    Exercise: $2.17Exp: 2034-08-12Common Stock (15,700 underlying)
Footnotes (1)
  • [F1]Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant.

Issuer

GeoVax Labs, Inc.

CIK 0000832489

Entity typeother

Related Parties

1
  • filerCIK 0001298237

Filing Metadata

Form type
4
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:10 PM ET
Size
5.2 KB